Medicare fixes typos in payment rules for doctors, drug rebates
What happened
This document corrects small errors in a proposed rule for how Medicare pays doctors and handles drug rebates. The changes are minor, mostly fixing typos and technical mistakes in the original text.
Why it matters
This document is a correction, not a new policy. It cleans up language in a proposed rule that will set payment rates for doctors and drug companies for 2026. The actual structural changes, if any, will come from the main proposed rule, not this correction.
The signal
The main proposed rule, once finalized, will show how Medicare payment rates for doctors and drug companies will change for 2026.